TC181

Phenotypic screening to identify small molecule inhibitors of Visceral Leishmaniasis and Chagas disease

...

Principal Investigator (PI)

...

Project location

the sponsor

Home Institution

Calibr

foundation funding

Foundation funding

The Foundation is providing £68,000 in support.

Open Labs Fellow/s

Irene Roquero

GSK’s contribution

GSK provides expertise and know-how in high throughput screening and later compound profilling, as well as access to key facilities to set-up and perform this work. GSK is also providing information about the parasitological and toxicological profile of the promising molecules identified.

Project Description